PR Newsiwre published the article provided by the Cancer Treatment Centers of America called “The National Football League Alumni Association, Cancer Treatment Centers of America and LabCorp Team Up to Offer Prostate Cancer Screenings Starting in September”. Prostate cancer affects nearly one in seven men, particularly African-American men. That’s why the National Football League Alumni Association, Cancer Treatment Centers of America and LabCorp teamed up to help raise awareness about this deadly cancer.
They are providing a variety of events and screenings to help educate and improve awareness about the cancer that affects so many men. From September through mid-October, the LabCorp will offer free screenings to 2,000 men who are qualified and over 40. Their Prostate Specific Antigen screening will be available at any of their locations around the states. After those free screenings have been used, LabCorp will offer screenings at an incredible discount of $25 dollars if the men sign up within the time allotted.
NFLA will add to the events with their Prostate Pep Talk Campaign. They have a variety of former NFL affiliates like Bill Cowher, Herm Edwards, and Dick Vermeil who will provide public service announcements during September’s campaign.
Cancer Treatment Centers of America is a network of hospitals dedicated to caring for their patients and helping them fight cancer. They are dedicated to bringing the advanced technology to their patients, creating a more modern care for their patients. They provide a team of experts to their patients all housed in the same location. The clinicians, nurses, and oncologists are all experts in their field and work exclusively with cancer patients.
The CTCA team includes board certified specialists in a variety of cancers including melanoma, throat, cervical, pancreatic, breast, lung, prostate, and throat cancer. There are a variety of treatment options available and the specialists understand that each patient and each cancer is unique. That’s why they provide precision cancer treatment, taking the fight to the cellular level.